beta glutathione Reduced with Cyclosome® Technology — Hi-Tech Pharmaceuticals genes involved in glutathione metabolism

Although most of the studies have been positive, their effect sizes were small

Approval to market 2% topical solution to women was granted October 1996

Intended Use: In-vitro receptor binding and cell-based assay research In-vivo preclinical metabolic research in approved animal models Laboratory investigation of amylin and GLP-1 receptor pharmacology Academic and institutional metabolic disease research Pharmaceutical research and drug discovery applications Veterinary research with appropriate IACUC approval NOT Intended For: Human consumption or administration Clinical trials without IND approval and regulatory oversight Treatment or prevention of any disease in humans Dietary supplementation or weight loss applications Veterinary therapeutic use without regulatory compliance Any use outside supervised laboratory research settings Safety Protocols: Follow standard laboratory safety practices: Personal protective equipment (lab coat, gloves, safety glasses) Handle in well-ventilated areas or fume hood Follow institutional biosafety and chemical hygiene guidelines Obtain IACUC approval for animal studies Complete required safety training Maintain Material Safety Data Sheets (MSDS/SDS) accessibility Dispose of waste according to institutional and regulatory requirements

Recommended Use: Drop 1 tablet in a glass of 200ml water, let it dissolve, and drink

Peptides do not neutralise retinol (unlike, say, mixing retinol with certain acids can be tricky)

Explore NICB Training Opportunities Visit our training calendar and register for upcoming opportunities online, via an instructor-led webinar, or in-person.